Mihic T, Socías ME, McCrae K, Johnson C, Nolan S, Grant C, Sutherland C, Fairbairn N Community pharmacy-based injectable opioid agonist treatment: findings from a Canadian pilot program Drug Alcohol Rev PubMed

Wellar A, Dennis B, Partridge S, Brar R, Johnson H(sɛƛakəs), Johnson C, Nolan S Road to recovery: a strategy to meaningfully address British Columbia's substance use system of care B C Med J Link

Dennis BB, Bowles J, Johnson C, De Wolfe T, Mundel E, Fast D, Boyd J, Fleury M, Bach P, Fairbairn N, Socías ME, Ti L, Hayashi K, DeBeck K, Milloy MJ, Felicella G, Morgan J, Eekhoudt CR, McGrail K, Richardson L, Ryan A, Mbuagbaw L, Guyatt G, Nolan S Road to Recovery: protocol for a mixed-methods prospective cohort study evaluating the impact of a new model of substance use care in a Canadian setting BMJ Open PubMed

Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study Subst Abuse Treat Prev Policy PubMed

Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs CJEM PubMed

Mitra S, Choi JC, van Draanen J, Kerr T, Gilbert M, Hayashi K, Milloy MJ, Johnson C, Richardson L Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: a longitudinal analysis Int J Drug Policy PubMed

Socías ME, Choi JC, Fairbairn N, Johnson C, Wilson D, DeBeck K, Brar R, Hayashi K Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis Int J Drug Policy PubMed